AstraZeneca and CSPC join forces to combat high cholesterol
In a move to strengthen its cardiovascular treatment portfolio, AstraZeneca announced a partnership with CSPC Pharmaceutical Group that could reach a staggering $1.92 billion. This [more…]
Category: China
Novo Nordisk’s Wegovy approved in China, faces patent challenges and competition
Novo Nordisk’s weight-loss drug Wegovy has received the green light in China, targeting the world’s second-largest economy and the country with the highest number of [more…]
Kobayashi Pharmaceutical links health issues to blue mold compound in Beni Kōji supplements
In a surprising turn, Kobayashi Pharmaceutical, the embattled drugmaker at the center of a health scandal involving its beni kōji (red yeast rice) dietary supplements, [more…]
Eisai’s Alzheimer’s drug Leqembi set for China rollout
Eisai plans to introduce its groundbreaking Alzheimer’s drug, Leqembi, to 1,500 people in China this year, with expectations of significant growth in 2025 as diagnosis [more…]